E6 Strips
E6 Strips, licence 80040107: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- E6 Strips Berry Energy, E6 Strips Cinnamon, E6 Strips Spearmint Energy, E6 Strips Tropical
- Licence holder
- Simcoe Asia Group
- NPN or DIN-HM
- 80040107
- Status
- Active licence
- Licence date
- 19 February 2013
- Revision date
- Not provided
- Form
- Pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 40.0 mg | Not calculated |
| Folate Source : Folate | 100.0 mcg | Not calculated |
Non-medicinal ingredients
Saveur, Glycérine, Eau purifiée, Huile de pépin de raisin, Cellulose, Chlorure de sodium, Acésulfame potassium, Laque d'aluminium jaune FD&C No. 5, FD&C Vert n° 3, Acide citrique, Feuille de Stevia rebaudiana, Lécithine, Xylitol, Pectine, Acide D-malique, Sucralose, Talc, Bleu FD&C n° 1, Fruit séché de goji
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Pellicule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Helps to promote alertness and wakefulness, and to enhance cognitive performance; Helps to relieve fatigue, to promote endurance and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80040107
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.